Portugal Spain France Iceland UK Ireland Belgium Netherlands Germany Denmark Norway Finland Sweden Switzerland Italy Austria Czech Republik Slovakia Croatia Poland Hungary Romania Greece Lithuania Latvia Estonia Belarus Ukraina Serbia & Montenegro Bulgaria Moldavia Macedonia Albania
Biotechnology and Pharma Switzerland
Biotechnology and Pharma Germany
Biotechnology and Pharma Sweden
Biotechnology and Pharma   UK
Biotechnology and Pharma  Ireland
Biotechnology and Pharma  France
Biotechnology and Pharma Italy
Biotechnology and Pharma Netherlands
Biotechnology and Pharma Belgium
Biotechnology and Pharma Norway
Biotechnology and Pharma Denmark
Biotechnology and Pharma  Austria
Biotechnology and Pharma  Greece
Biotechnology and Pharma Finland
Biotechnology and Pharma Spain
Biotechnology and Pharma Hungary
Biotechnology and Pharma Russia
Biotechnology and Pharma Czech Republic
Biotechnology and Pharma Estonia
Biotechnology and Pharma Poland
Biotechnology and Pharma Portugal
Biotechnology and Pharma  Slovakia
Biotechnology and Pharma Lithuania
Biotechnology and Pharma  Iceland
Biotechnology and Pharma Slovenia
Biotechnology and Pharma Bulgaria
Biotechnology and Pharma Romania
Biotechnologyand Pharma Macedonia
Biotechnology and Pharma Albania
Biotechnology and Pharma Luxembourg
Biotechnology and Pharma Serbia
Biotechnology and Pharma Cyprus
Biotechnology and Pharma Malta
Biotechnology and Pharma Belarus
Biotechnology and Pharma Croatia
Biotechnology and Pharma Ukraina
Biotechnology and Pharma Turkey
 

 
 

New compound offers attractive therapeutic candidate for autoimmune inflammatory diseases
 

A new way to increase the numbers of mobilized stem cells
 

New Microneedle Applicator Device
 

Novel compound offers new treatment approach for ovarian cancer
 

A diagnostic marker for early cancer detection
 
  Sulidin® nimesulide LPS Non-Steroidal Topical Anti-inflammatory gel for the local treatment of painful inflammatory conditions
 

 
29.08.2008 Oxford Biomedica plc Unaudited Interim Results for the Six Months Ended 30 June 2008
 
26.08.2008 ADAGIO trial results show Azilect® slows progression of Parkinson's disease
 
25.08.2008 Cell Therapeutics, Inc. Announces Reverse Stock Split
 
22.08.2008 FDA Approves NplateTM for Long-Term Treatment of Adult Chronic ITP
 
20.08.2008 JAMA Publishes Study Results on Efficacy of the Bard Agento(R) I.C. Silver-Coated Endotracheal Tube in Preventing Ventilator-Associated Pneumonia
 
20.08.2008 Avantogen Ltd Receives Commitment of $1M in a Private Placement
 
19.08.2008 BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
 
19.08.2008 European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy
 
15.08.2008 Evidence of activity seen in new data from ASA404 prostate cancer trial
 
13.08.2008 MOLOGEN AG publishes results for the first half-year of 2008
 
13.08.2008 Genentech Special Committee of Independent Directors Responds to Roche Proposal